Latest stories on CANF
Can-Fite BioPharma Posts Positive Phase 2a Signal for Namodenoson in Pancreatic Cancer
TipRanks67 · bullishproduct/pr
Can-Fite BioPharma Adjourns 2026 Shareholder Meeting for Lack of Quorum
TipRanks50 · neutralgeneral
CANF news roundup. 2 stories in the past week, 3 over 30 days. Average 30-day sentiment is 61.3/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.